Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.2 |
mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.2 |
mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.073 | 0.2 |
mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.2 |
mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.063 | 0.2 |